New mRNA Pancreatic Cancer Vaccine Trial Starts Next Phase

A new experimental approach to treating pancreatic cancer is progressing to the next step in making it available to more patients. After results from a small study, a phase II clinical trial has now opened to test the effectiveness of using an mRNA vaccine to fight one of the deadliest cancers.